Search Result "type IV inhibitors."
Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 35 Year: 2014 Page: 4013-4045
Author(s): R.N. Kushwaha,W. Haq,S.B. Katti
Aromatic Heterocycle-Based DPP-IV Inhibitors: Xanthines and Related Structural Types.
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 569-578
Author(s): Bruce G. Szczepankiewicz, Ravi Kurukulasuriya
The Therapeutic Potential of Inhibitors of Dipeptidyl Peptidase IV (DPP IV) and Related Proline-Specific Dipeptidyl Aminopeptidases
Journal: Current Medicinal Chemistry
Volume: 12 Issue: 8 Year: 2005 Page: 971-998
Author(s): K. Augustyns, P. Van der Veken, K. Senten, A. Haemers
Progress in the Oral Treatment of Type 2 Diabetes: Update on DPP-IV Inhibitors
Journal: Current Diabetes Reviews
Volume: 5 Issue: 2 Year: 2009 Page: 92-101
Author(s): Teresa Salvatore, Ornella Carbonara, Domenico Cozzolino, Roberto Torella, Ferdinando C. Sasso
Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV)
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 597-608
Author(s): Dana Ferraris, Sergei Belyakov, Weixing Li, Eddie Oliver, Yao-Sen Ko, David Calvin, Susan Lautar, Bert Thomas, Camilo Rojas
11 Years of Cyanopyrrolidines as DPP-IV Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 579-595
Author(s): Jens-Uwe Peters
Neural Pathways and Neuropeptides Mediate the Therapeutic Actions of DPP IV Inhibitors in Type-2 Diabetes
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 1 Issue: 2 Year: 2007 Page: 132-135
Author(s): Adnan Erol
Computational Identification of Inhibitors Against DPP-IV for Checking Type-2 Diabetes
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 1 Year: 2017 Page: 66-73
Author(s): Sarvesh Kumar Gupta,Kamal Kumar Chaudhary,Utkarsh Raj,Nidhi Mishra
Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes
Journal: Current Drug Targets
Volume: 10 Issue: 1 Year: 2009 Page: 71-87
Author(s): Rajesh Gupta, Sameer S. Walunj, Ranjeet K. Tokala, Kishore V.L. Parsa, Santosh Kumar Singh, Manojit Pal
Dipeptidyl Peptidase-IV Inhibitors: An Evolving Treatment for Type 2 Diabetes from the Incretin Concept
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 1 Issue: 1 Year: 2007 Page: 15-24
Author(s): Yau-Jan Chyan, Lee-Ming Chuang